\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes Digital, Industry & Space Climate, Energy, MobilitySustainable Energy Days are events and activities held globally to promote clean energy and energy efficiency. Featuring a variety of formats - from civil society meetings to educational forums and even artistic interventions - these events provide a platform for individuals, organisations, and communities to inspire behavioural change and accelerate innovation towards achieving the EU’s energy and climate goals.
With the current global focus on energy transition and energy independence, Sustainable Energy Days play a key role in fostering sustainable energy solutions in the EU and around the world.
The call to submit your proposal for a Sustainable Energy Day is now open.
Are you thinking about applying to earn the title of Sustainable Energy Day? Read the guidelines and discover how your action can drive Europe’s clean energy future.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
